Daily Sequential Organ Failure Assessment ( SOFA ) score and the cumulative time in a 4.0 to 7.0 mmol/L band ( cTIB ) were evaluated daily up to 14 days in 704 participants of the multicentre Glucontrol trial ( 16 centers ) that randomized patients to intensive group A ( blood glucose [ BG ] target : 4.4-6 .1 mmol/L ) or conventional group B ( BG target : 7.8-10 .0 mmol/L ) .